Financial Health Check: Examining Arbutus Biopharma Corp (ABUS)’s Key Ratios

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.83 million shares were traded.

Ratios:

For a better understanding of ABUS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.02 and its Current Ratio is at 7.02. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.

On February 25, 2021, Jefferies started tracking the stock assigning a Hold rating and target price of $5.

On December 17, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on December 17, 2020, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 19 ’25 when Sofia Michael J. bought 150,000 shares for $3.20 per share.

Sofia Michael J. bought 100,000 shares of ABUS for $338,000 on Mar 13 ’25. On Mar 07 ’25, another insider, Sofia Michael J., who serves as the Member of immediate family of of the company, bought 167,162 shares for $3.29 each.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 93.06 while its Price-to-Book (P/B) ratio in mrq is 5.87.

Stock Price History:

Over the past 52 weeks, ABUS has reached a high of $4.72, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is -0.58%, while the 200-Day Moving Average is calculated to be -7.74%.

Shares Statistics:

A total of 189.44M shares are outstanding, with a floating share count of 147.08M. Insiders hold about 22.38% of the company’s shares, while institutions hold 54.97% stake in the company.

Most Popular